Kathryn Horwitz
Concepts (514)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Progesterone | 112 | 2020 | 342 | 10.410 |
Why?
| Breast Neoplasms | 119 | 2021 | 2116 | 6.360 |
Why?
| Progesterone | 47 | 2021 | 244 | 5.210 |
Why?
| Receptors, Estrogen | 57 | 2014 | 423 | 3.950 |
Why?
| Progestins | 23 | 2021 | 78 | 2.800 |
Why?
| Estrogens | 17 | 2014 | 348 | 2.010 |
Why?
| Gene Expression Regulation, Neoplastic | 21 | 2015 | 1318 | 1.890 |
Why?
| Tamoxifen | 26 | 2012 | 198 | 1.730 |
Why?
| Transcription, Genetic | 29 | 2012 | 1409 | 1.670 |
Why?
| Estradiol | 28 | 2014 | 494 | 1.640 |
Why?
| SUMO-1 Protein | 4 | 2012 | 20 | 0.970 |
Why?
| Tumor Cells, Cultured | 32 | 2009 | 929 | 0.790 |
Why?
| Gene Expression Profiling | 13 | 2014 | 1696 | 0.760 |
Why?
| Keratin-5 | 4 | 2014 | 49 | 0.740 |
Why?
| Neoplasms, Hormone-Dependent | 8 | 2010 | 38 | 0.710 |
Why?
| Promegestone | 24 | 2005 | 33 | 0.680 |
Why?
| Transcription Factors | 12 | 2009 | 1636 | 0.650 |
Why?
| Gene Expression Regulation | 10 | 2011 | 2523 | 0.630 |
Why?
| Biomarkers, Tumor | 8 | 2020 | 1174 | 0.620 |
Why?
| Stromal Cells | 5 | 2014 | 104 | 0.620 |
Why?
| Cell Proliferation | 9 | 2014 | 2344 | 0.610 |
Why?
| Protein Processing, Post-Translational | 4 | 2013 | 448 | 0.580 |
Why?
| HeLa Cells | 15 | 2012 | 602 | 0.570 |
Why?
| Promoter Regions, Genetic | 12 | 2012 | 1195 | 0.570 |
Why?
| Female | 106 | 2021 | 68274 | 0.560 |
Why?
| Estrogen Replacement Therapy | 2 | 2008 | 141 | 0.560 |
Why?
| Humans | 157 | 2021 | 129078 | 0.550 |
Why?
| Cell Line, Tumor | 19 | 2014 | 3114 | 0.540 |
Why?
| Medroxyprogesterone Acetate | 3 | 2005 | 35 | 0.520 |
Why?
| Cell Nucleus | 27 | 2008 | 571 | 0.490 |
Why?
| Antineoplastic Agents, Hormonal | 6 | 2010 | 157 | 0.480 |
Why?
| Mifepristone | 11 | 2000 | 62 | 0.480 |
Why?
| Neovascularization, Pathologic | 2 | 2014 | 296 | 0.480 |
Why?
| Neoplastic Stem Cells | 3 | 2008 | 376 | 0.480 |
Why?
| Lymphatic Metastasis | 4 | 2010 | 312 | 0.480 |
Why?
| Animals | 54 | 2014 | 34708 | 0.470 |
Why?
| Phosphorylation | 19 | 2013 | 1686 | 0.470 |
Why?
| Down-Regulation | 9 | 2009 | 639 | 0.470 |
Why?
| Platelet-Derived Growth Factor | 2 | 2014 | 89 | 0.470 |
Why?
| Mice | 27 | 2014 | 16583 | 0.460 |
Why?
| Molecular Sequence Data | 21 | 2009 | 2846 | 0.460 |
Why?
| Epigenomics | 1 | 2015 | 111 | 0.450 |
Why?
| Histone Acetyltransferases | 4 | 2012 | 63 | 0.450 |
Why?
| Epidermal Growth Factor | 8 | 2005 | 170 | 0.440 |
Why?
| Transcriptional Activation | 9 | 2009 | 361 | 0.440 |
Why?
| Epithelium | 3 | 2013 | 312 | 0.420 |
Why?
| Mice, Nude | 9 | 2012 | 680 | 0.420 |
Why?
| Cell Line | 35 | 2009 | 2762 | 0.390 |
Why?
| Cell Division | 12 | 2003 | 802 | 0.390 |
Why?
| Protein Isoforms | 6 | 2011 | 370 | 0.390 |
Why?
| MCF-7 Cells | 4 | 2020 | 109 | 0.390 |
Why?
| Binding Sites | 15 | 2006 | 1239 | 0.380 |
Why?
| DNA-Binding Proteins | 10 | 2000 | 1424 | 0.380 |
Why?
| Enzyme Inhibitors | 3 | 2008 | 829 | 0.380 |
Why?
| Models, Biological | 5 | 2014 | 1704 | 0.370 |
Why?
| Signal Transduction | 18 | 2012 | 4867 | 0.370 |
Why?
| Repressor Proteins | 5 | 2002 | 400 | 0.370 |
Why?
| Cyclins | 4 | 1999 | 86 | 0.360 |
Why?
| Neoplasm Proteins | 4 | 2005 | 428 | 0.360 |
Why?
| Receptors, Notch | 1 | 2011 | 86 | 0.360 |
Why?
| DNA | 11 | 2000 | 1407 | 0.360 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.340 |
Why?
| Epigenesis, Genetic | 1 | 2015 | 613 | 0.340 |
Why?
| Peritoneal Neoplasms | 1 | 2010 | 83 | 0.340 |
Why?
| DNA Methylation | 1 | 2015 | 602 | 0.330 |
Why?
| Nuclear Proteins | 7 | 2000 | 644 | 0.330 |
Why?
| Transplantation, Heterologous | 6 | 2009 | 190 | 0.330 |
Why?
| Adenocarcinoma | 2 | 2014 | 898 | 0.330 |
Why?
| Alu Elements | 1 | 2009 | 27 | 0.320 |
Why?
| Milk Proteins | 2 | 1999 | 37 | 0.310 |
Why?
| Drug Resistance, Neoplasm | 6 | 2010 | 738 | 0.310 |
Why?
| Neoplasm Metastasis | 5 | 2020 | 608 | 0.310 |
Why?
| Neoplasm Transplantation | 4 | 2014 | 255 | 0.310 |
Why?
| Neoplasm Recurrence, Local | 4 | 2013 | 952 | 0.300 |
Why?
| Amino Acid Sequence | 12 | 2009 | 2050 | 0.300 |
Why?
| Protein Multimerization | 1 | 2009 | 178 | 0.290 |
Why?
| Aromatase Inhibitors | 1 | 2008 | 51 | 0.290 |
Why?
| Nuclear Receptor Coactivator 1 | 4 | 2012 | 10 | 0.290 |
Why?
| Cyclic AMP | 5 | 2006 | 230 | 0.280 |
Why?
| Saccharomyces cerevisiae Proteins | 2 | 2001 | 367 | 0.280 |
Why?
| Cysteine Endopeptidases | 3 | 2012 | 67 | 0.280 |
Why?
| Ligands | 10 | 2009 | 616 | 0.270 |
Why?
| Cell Fusion | 1 | 2006 | 51 | 0.270 |
Why?
| Breast | 5 | 2001 | 149 | 0.260 |
Why?
| Selective Estrogen Receptor Modulators | 2 | 2010 | 26 | 0.250 |
Why?
| Models, Theoretical | 2 | 2008 | 550 | 0.250 |
Why?
| Trans-Activators | 5 | 1999 | 387 | 0.250 |
Why?
| Ovarian Neoplasms | 1 | 2010 | 484 | 0.240 |
Why?
| Base Sequence | 11 | 2009 | 2157 | 0.240 |
Why?
| Protein Binding | 10 | 2009 | 2087 | 0.230 |
Why?
| DNA, Neoplasm | 6 | 1992 | 162 | 0.230 |
Why?
| RNA, Messenger | 11 | 2010 | 2702 | 0.230 |
Why?
| Epithelial Cells | 2 | 2010 | 1063 | 0.220 |
Why?
| Lymph Nodes | 1 | 2006 | 459 | 0.220 |
Why?
| Gonanes | 5 | 1997 | 27 | 0.220 |
Why?
| Drug Resistance | 8 | 2000 | 167 | 0.220 |
Why?
| Cell Growth Processes | 3 | 2010 | 52 | 0.220 |
Why?
| Estrogen Receptor Modulators | 3 | 2008 | 17 | 0.210 |
Why?
| Receptors, Steroid | 4 | 1999 | 47 | 0.210 |
Why?
| Mutation | 7 | 2012 | 3679 | 0.210 |
Why?
| Sumoylation | 2 | 2013 | 16 | 0.210 |
Why?
| Molecular Weight | 11 | 2000 | 332 | 0.210 |
Why?
| Receptors, Cell Surface | 7 | 1994 | 379 | 0.210 |
Why?
| Peptide Fragments | 5 | 2003 | 694 | 0.200 |
Why?
| Disease Models, Animal | 4 | 2014 | 3999 | 0.200 |
Why?
| ErbB Receptors | 4 | 2020 | 602 | 0.200 |
Why?
| Phosphoserine | 2 | 2000 | 31 | 0.190 |
Why?
| Xenograft Model Antitumor Assays | 4 | 2012 | 799 | 0.190 |
Why?
| Norpregnadienes | 3 | 1988 | 7 | 0.190 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 181 | 0.190 |
Why?
| Antibodies, Monoclonal | 9 | 2006 | 1361 | 0.180 |
Why?
| Leucine Zippers | 3 | 1997 | 16 | 0.180 |
Why?
| Immunohistochemistry | 6 | 2008 | 1697 | 0.180 |
Why?
| Transfection | 8 | 2006 | 907 | 0.180 |
Why?
| Multienzyme Complexes | 2 | 2003 | 69 | 0.180 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2000 | 312 | 0.180 |
Why?
| Antigens, Nuclear | 1 | 2000 | 20 | 0.170 |
Why?
| Recombinant Fusion Proteins | 6 | 2000 | 642 | 0.170 |
Why?
| Homeodomain Proteins | 3 | 2009 | 480 | 0.170 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 957 | 0.170 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2000 | 89 | 0.170 |
Why?
| Estrogen Antagonists | 11 | 2000 | 45 | 0.170 |
Why?
| Response Elements | 3 | 2009 | 87 | 0.160 |
Why?
| Prolactin | 2 | 1998 | 99 | 0.160 |
Why?
| Receptor Cross-Talk | 1 | 1998 | 21 | 0.160 |
Why?
| Amino Acid Motifs | 3 | 2006 | 210 | 0.160 |
Why?
| MAP Kinase Signaling System | 2 | 2001 | 305 | 0.160 |
Why?
| Kinetics | 15 | 2001 | 1622 | 0.160 |
Why?
| Hormone Antagonists | 2 | 1997 | 30 | 0.150 |
Why?
| Disease Susceptibility | 1 | 2021 | 338 | 0.150 |
Why?
| Carcinogenesis | 1 | 2020 | 201 | 0.150 |
Why?
| Tumor Suppressor Proteins | 2 | 1998 | 313 | 0.150 |
Why?
| DNA Helicases | 1 | 2000 | 149 | 0.150 |
Why?
| Protein Structure, Tertiary | 3 | 2012 | 835 | 0.150 |
Why?
| Proto-Oncogene Proteins c-fos | 2 | 1998 | 173 | 0.150 |
Why?
| Progesterone Congeners | 5 | 2008 | 16 | 0.150 |
Why?
| Risk | 1 | 2021 | 867 | 0.150 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 1999 | 115 | 0.150 |
Why?
| Affinity Labels | 9 | 1990 | 25 | 0.150 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2010 | 772 | 0.140 |
Why?
| Oxygenases | 1 | 1997 | 10 | 0.140 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 2 | 2012 | 130 | 0.140 |
Why?
| CDC2-CDC28 Kinases | 1 | 1997 | 20 | 0.140 |
Why?
| Mutagenesis, Site-Directed | 5 | 2001 | 357 | 0.140 |
Why?
| Nafoxidine | 8 | 1982 | 9 | 0.140 |
Why?
| Endometrium | 2 | 2008 | 61 | 0.140 |
Why?
| Endometrial Neoplasms | 4 | 2008 | 163 | 0.140 |
Why?
| Phosphoproteins | 3 | 2008 | 326 | 0.140 |
Why?
| Immunoblotting | 4 | 2004 | 302 | 0.140 |
Why?
| Hyaluronan Receptors | 2 | 2008 | 93 | 0.140 |
Why?
| Endopeptidases | 2 | 2012 | 82 | 0.140 |
Why?
| Carcinogens | 1 | 1997 | 111 | 0.140 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1994 | 20 | 0.140 |
Why?
| Ribosomal Proteins | 1 | 1997 | 76 | 0.140 |
Why?
| Carcinoma, Endometrioid | 2 | 2008 | 46 | 0.140 |
Why?
| Cytoplasm | 12 | 2006 | 260 | 0.140 |
Why?
| Muscle, Smooth, Vascular | 4 | 2000 | 430 | 0.130 |
Why?
| Up-Regulation | 3 | 2009 | 850 | 0.130 |
Why?
| Cluster Analysis | 4 | 2008 | 479 | 0.130 |
Why?
| Microtubule-Associated Proteins | 1 | 1997 | 183 | 0.130 |
Why?
| Mammary Neoplasms, Experimental | 8 | 2009 | 66 | 0.130 |
Why?
| Blotting, Western | 6 | 2010 | 1189 | 0.130 |
Why?
| Apoptosis | 5 | 2011 | 2485 | 0.130 |
Why?
| Receptors, Glucocorticoid | 8 | 2000 | 145 | 0.120 |
Why?
| Consensus Sequence | 2 | 2009 | 72 | 0.120 |
Why?
| Tumor Microenvironment | 2 | 2020 | 596 | 0.120 |
Why?
| Phenotype | 5 | 2011 | 3062 | 0.120 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 1996 | 210 | 0.120 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 1994 | 52 | 0.120 |
Why?
| Methylation | 1 | 2015 | 228 | 0.110 |
Why?
| Heterografts | 1 | 2014 | 129 | 0.110 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 95 | 0.110 |
Why?
| Fibroblasts | 2 | 2020 | 946 | 0.110 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2014 | 195 | 0.110 |
Why?
| Small Molecule Libraries | 1 | 2014 | 85 | 0.110 |
Why?
| Cell Cycle Proteins | 1 | 1997 | 576 | 0.110 |
Why?
| Ubiquitination | 1 | 2013 | 96 | 0.110 |
Why?
| Estrenes | 4 | 1989 | 16 | 0.110 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2006 | 422 | 0.110 |
Why?
| Immunoenzyme Techniques | 2 | 2010 | 210 | 0.110 |
Why?
| Immunophenotyping | 1 | 2014 | 311 | 0.100 |
Why?
| Drug Synergism | 4 | 1998 | 354 | 0.100 |
Why?
| Acetylation | 1 | 2013 | 235 | 0.100 |
Why?
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 25 | 0.100 |
Why?
| Pregnancy Complications, Neoplastic | 1 | 2013 | 52 | 0.100 |
Why?
| Chickens | 6 | 1994 | 188 | 0.100 |
Why?
| Carcinoma, Lobular | 1 | 2012 | 46 | 0.100 |
Why?
| DNA, Complementary | 4 | 2001 | 270 | 0.100 |
Why?
| Bone Neoplasms | 1 | 2014 | 227 | 0.100 |
Why?
| Disease Progression | 3 | 2014 | 2607 | 0.100 |
Why?
| Claudins | 1 | 2011 | 25 | 0.090 |
Why?
| Cytosol | 9 | 1989 | 210 | 0.090 |
Why?
| Cells, Cultured | 10 | 2006 | 4063 | 0.090 |
Why?
| Bridged-Ring Compounds | 1 | 2011 | 13 | 0.090 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2011 | 24 | 0.090 |
Why?
| Pyrrolidines | 3 | 1981 | 65 | 0.090 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2011 | 78 | 0.090 |
Why?
| Nuclear Receptor Co-Repressor 1 | 3 | 2000 | 16 | 0.090 |
Why?
| Estrogen Receptor alpha | 2 | 2010 | 131 | 0.090 |
Why?
| Polyploidy | 1 | 1990 | 18 | 0.090 |
Why?
| Neoplasms, Experimental | 4 | 2008 | 168 | 0.090 |
Why?
| Taxoids | 1 | 2011 | 98 | 0.090 |
Why?
| Genome, Human | 1 | 2013 | 393 | 0.090 |
Why?
| Receptor, Insulin | 3 | 1985 | 99 | 0.090 |
Why?
| Acetylcysteine | 2 | 2003 | 148 | 0.090 |
Why?
| COS Cells | 2 | 2003 | 185 | 0.090 |
Why?
| Hormones | 2 | 1993 | 139 | 0.080 |
Why?
| Cloning, Molecular | 4 | 2006 | 536 | 0.080 |
Why?
| Organ Specificity | 1 | 2010 | 296 | 0.080 |
Why?
| Chemokine CXCL12 | 1 | 2010 | 79 | 0.080 |
Why?
| Histones | 1 | 2015 | 584 | 0.080 |
Why?
| Antineoplastic Agents | 2 | 2008 | 2043 | 0.080 |
Why?
| Liver Neoplasms | 1 | 2014 | 637 | 0.080 |
Why?
| Epitopes | 1 | 1991 | 469 | 0.080 |
Why?
| Nuclear Receptor Co-Repressor 2 | 2 | 2000 | 15 | 0.080 |
Why?
| Time Factors | 4 | 2008 | 6579 | 0.080 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2009 | 150 | 0.080 |
Why?
| Receptors, Androgen | 5 | 2005 | 143 | 0.080 |
Why?
| Transformation, Genetic | 1 | 1988 | 16 | 0.080 |
Why?
| Neoadjuvant Therapy | 2 | 2010 | 383 | 0.080 |
Why?
| STAT5 Transcription Factor | 2 | 1999 | 47 | 0.080 |
Why?
| Drug Administration Routes | 1 | 2008 | 39 | 0.080 |
Why?
| Embryonal Carcinoma Stem Cells | 1 | 2008 | 2 | 0.080 |
Why?
| Mitogen-Activated Protein Kinase 3 | 2 | 2000 | 155 | 0.080 |
Why?
| Protein Precursors | 1 | 1989 | 126 | 0.080 |
Why?
| Mitogen-Activated Protein Kinase 1 | 2 | 2000 | 185 | 0.080 |
Why?
| Transcriptome | 1 | 2014 | 875 | 0.080 |
Why?
| MicroRNAs | 1 | 2015 | 669 | 0.070 |
Why?
| Substrate Specificity | 1 | 2009 | 372 | 0.070 |
Why?
| Microdissection | 1 | 2007 | 16 | 0.070 |
Why?
| Mammary Tumor Virus, Mouse | 2 | 2000 | 42 | 0.070 |
Why?
| Dactinomycin | 4 | 1981 | 29 | 0.070 |
Why?
| Androstadienes | 1 | 2008 | 107 | 0.070 |
Why?
| Binding, Competitive | 6 | 1994 | 208 | 0.070 |
Why?
| Pregnanes | 1 | 1986 | 3 | 0.070 |
Why?
| Lasers | 1 | 2007 | 131 | 0.070 |
Why?
| Structure-Activity Relationship | 2 | 2002 | 540 | 0.070 |
Why?
| Transforming Growth Factor beta | 1 | 2009 | 460 | 0.070 |
Why?
| Pregnanolone | 1 | 1986 | 27 | 0.070 |
Why?
| Receptor, IGF Type 1 | 1 | 2006 | 64 | 0.070 |
Why?
| Recombinant Proteins | 3 | 2003 | 1306 | 0.070 |
Why?
| Neoplasm Invasiveness | 3 | 2020 | 480 | 0.070 |
Why?
| Protein Biosynthesis | 3 | 2000 | 409 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2008 | 760 | 0.070 |
Why?
| Menopause | 3 | 2008 | 301 | 0.060 |
Why?
| Pleural Effusion | 1 | 2006 | 52 | 0.060 |
Why?
| Cell Cycle | 2 | 1999 | 582 | 0.060 |
Why?
| Mutant Proteins | 1 | 2006 | 97 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 5 | 2005 | 1974 | 0.060 |
Why?
| Brain Neoplasms | 1 | 2014 | 1138 | 0.060 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2006 | 44 | 0.060 |
Why?
| Zinc Fingers | 2 | 1998 | 43 | 0.060 |
Why?
| Chromatography, Affinity | 4 | 1990 | 83 | 0.060 |
Why?
| Methionine | 2 | 2000 | 158 | 0.060 |
Why?
| Gene Regulatory Networks | 1 | 2007 | 279 | 0.060 |
Why?
| Regulatory Sequences, Nucleic Acid | 3 | 1997 | 88 | 0.060 |
Why?
| Protein Structure, Secondary | 1 | 2006 | 335 | 0.060 |
Why?
| Hydroxyprogesterones | 1 | 1985 | 1 | 0.060 |
Why?
| Chromosome Mapping | 4 | 1999 | 505 | 0.060 |
Why?
| Keratins | 1 | 2005 | 176 | 0.060 |
Why?
| Uterine Neoplasms | 1 | 2006 | 101 | 0.060 |
Why?
| Thromboplastin | 1 | 2004 | 75 | 0.060 |
Why?
| Cycloheximide | 4 | 1989 | 55 | 0.060 |
Why?
| Dexamethasone | 5 | 2000 | 331 | 0.060 |
Why?
| Chloramphenicol O-Acetyltransferase | 2 | 1994 | 37 | 0.060 |
Why?
| Protein Conformation | 2 | 2001 | 853 | 0.060 |
Why?
| Dimerization | 2 | 2002 | 189 | 0.060 |
Why?
| Cell Transformation, Neoplastic | 1 | 2006 | 322 | 0.060 |
Why?
| Patient Care Planning | 1 | 2005 | 152 | 0.060 |
Why?
| Cell Movement | 2 | 2006 | 935 | 0.050 |
Why?
| Paclitaxel | 1 | 2004 | 214 | 0.050 |
Why?
| Microscopy, Confocal | 1 | 2004 | 308 | 0.050 |
Why?
| Plasmids | 2 | 2002 | 358 | 0.050 |
Why?
| Genes, Reporter | 2 | 1994 | 269 | 0.050 |
Why?
| Cell Adhesion | 1 | 2004 | 452 | 0.050 |
Why?
| Biomarkers | 1 | 2014 | 3878 | 0.050 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2003 | 145 | 0.050 |
Why?
| Analysis of Variance | 1 | 2005 | 1285 | 0.050 |
Why?
| Sequence Alignment | 1 | 2003 | 333 | 0.050 |
Why?
| Sequence Homology, Amino Acid | 1 | 2003 | 370 | 0.050 |
Why?
| Mutagenesis | 1 | 2003 | 179 | 0.050 |
Why?
| Oligodeoxyribonucleotides | 2 | 1993 | 138 | 0.050 |
Why?
| Biomedical Research | 1 | 2008 | 654 | 0.050 |
Why?
| Flow Cytometry | 3 | 1992 | 1147 | 0.050 |
Why?
| Uterus | 1 | 2003 | 204 | 0.050 |
Why?
| Testosterone | 1 | 2005 | 382 | 0.050 |
Why?
| Iron Chelating Agents | 1 | 2001 | 18 | 0.050 |
Why?
| Lung Neoplasms | 1 | 2014 | 2357 | 0.050 |
Why?
| MAP Kinase Kinase Kinase 1 | 1 | 2001 | 19 | 0.050 |
Why?
| Oligonucleotide Probes | 2 | 1992 | 54 | 0.050 |
Why?
| Pregnancy | 2 | 2013 | 6256 | 0.050 |
Why?
| Androgens | 7 | 1986 | 173 | 0.050 |
Why?
| Growth Substances | 2 | 1999 | 155 | 0.050 |
Why?
| Cell Differentiation | 2 | 2006 | 1858 | 0.050 |
Why?
| Oviducts | 3 | 1986 | 17 | 0.050 |
Why?
| Ultracentrifugation | 1 | 2001 | 48 | 0.050 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2004 | 529 | 0.050 |
Why?
| Gene Library | 2 | 1992 | 118 | 0.050 |
Why?
| Sequence Deletion | 1 | 2001 | 180 | 0.040 |
Why?
| Genetic Variation | 2 | 1999 | 935 | 0.040 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 37 | 0.040 |
Why?
| Ku Autoantigen | 1 | 2000 | 13 | 0.040 |
Why?
| Exons | 2 | 1999 | 332 | 0.040 |
Why?
| DNA-Activated Protein Kinase | 1 | 2000 | 16 | 0.040 |
Why?
| Ubiquitins | 1 | 2000 | 37 | 0.040 |
Why?
| CD146 Antigen | 1 | 2020 | 41 | 0.040 |
Why?
| Glutathione Transferase | 1 | 2000 | 98 | 0.040 |
Why?
| Peptides, Cyclic | 1 | 2001 | 258 | 0.040 |
Why?
| Phosphates | 2 | 1993 | 168 | 0.040 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 1999 | 55 | 0.040 |
Why?
| Nucleic Acid Hybridization | 2 | 1990 | 191 | 0.040 |
Why?
| Phosphotyrosine | 1 | 1998 | 36 | 0.040 |
Why?
| Receptors, Growth Factor | 1 | 1998 | 55 | 0.040 |
Why?
| Imidazoles | 1 | 2000 | 225 | 0.040 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 1998 | 52 | 0.040 |
Why?
| STAT1 Transcription Factor | 1 | 1998 | 69 | 0.040 |
Why?
| Protein Folding | 1 | 2000 | 263 | 0.040 |
Why?
| Immunoassay | 2 | 1989 | 101 | 0.040 |
Why?
| Sp1 Transcription Factor | 1 | 1998 | 25 | 0.040 |
Why?
| Middle Aged | 6 | 2013 | 31024 | 0.040 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 160 | 0.040 |
Why?
| Suppression, Genetic | 1 | 1998 | 24 | 0.040 |
Why?
| Rats | 9 | 1991 | 5254 | 0.040 |
Why?
| Hydrocortisone | 3 | 1985 | 300 | 0.040 |
Why?
| Cyclin B | 1 | 1997 | 15 | 0.040 |
Why?
| Cyclin A | 1 | 1997 | 17 | 0.040 |
Why?
| Glycoproteins | 1 | 2000 | 340 | 0.040 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 268 | 0.040 |
Why?
| Dihydrotestosterone | 3 | 1979 | 39 | 0.040 |
Why?
| Isomerism | 1 | 1997 | 48 | 0.040 |
Why?
| Cell Compartmentation | 3 | 1989 | 52 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1997 | 71 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1997 | 68 | 0.040 |
Why?
| G1 Phase | 1 | 1997 | 70 | 0.040 |
Why?
| Biological Transport | 1 | 1998 | 394 | 0.040 |
Why?
| Cyclin-Dependent Kinase 2 | 1 | 1997 | 38 | 0.040 |
Why?
| Zinc Finger E-box-Binding Homeobox 1 | 2 | 2008 | 24 | 0.040 |
Why?
| Blood Platelets | 2 | 1994 | 370 | 0.030 |
Why?
| Yeasts | 1 | 1997 | 54 | 0.030 |
Why?
| Autoantigens | 1 | 2000 | 414 | 0.030 |
Why?
| STAT3 Transcription Factor | 1 | 1998 | 187 | 0.030 |
Why?
| Chromatin | 1 | 2000 | 471 | 0.030 |
Why?
| Gas Chromatography-Mass Spectrometry | 2 | 1986 | 126 | 0.030 |
Why?
| Cyclin-Dependent Kinases | 1 | 1997 | 129 | 0.030 |
Why?
| Pyridines | 1 | 2000 | 472 | 0.030 |
Why?
| Photochemistry | 2 | 1990 | 131 | 0.030 |
Why?
| Gene Expression | 3 | 2006 | 1477 | 0.030 |
Why?
| Centrifugation, Density Gradient | 4 | 1983 | 39 | 0.030 |
Why?
| Adult | 5 | 2013 | 35423 | 0.030 |
Why?
| Precipitin Tests | 2 | 2000 | 94 | 0.030 |
Why?
| Membrane Proteins | 1 | 2001 | 1102 | 0.030 |
Why?
| Prognosis | 4 | 2009 | 3793 | 0.030 |
Why?
| Molecular Structure | 1 | 1996 | 469 | 0.030 |
Why?
| TATA Box | 1 | 1994 | 24 | 0.030 |
Why?
| Protein Kinases | 2 | 2008 | 305 | 0.030 |
Why?
| Biopolymers | 1 | 1994 | 32 | 0.030 |
Why?
| Adenosine Diphosphate | 1 | 1994 | 79 | 0.030 |
Why?
| Risk Factors | 1 | 2008 | 9804 | 0.030 |
Why?
| Estradiol Congeners | 3 | 1981 | 3 | 0.030 |
Why?
| Chromatography, DEAE-Cellulose | 2 | 1985 | 13 | 0.030 |
Why?
| Genes, jun | 1 | 1993 | 9 | 0.030 |
Why?
| Glucocorticoids | 6 | 2000 | 571 | 0.030 |
Why?
| Genes, fos | 1 | 1993 | 33 | 0.030 |
Why?
| Antibodies | 2 | 1986 | 393 | 0.030 |
Why?
| Aneuploidy | 1 | 1994 | 92 | 0.030 |
Why?
| In Vitro Techniques | 1 | 1995 | 1061 | 0.030 |
Why?
| beta-Galactosidase | 1 | 1993 | 75 | 0.030 |
Why?
| Macromolecular Substances | 2 | 1983 | 212 | 0.030 |
Why?
| Karyotyping | 1 | 2012 | 107 | 0.030 |
Why?
| Castration | 4 | 1982 | 14 | 0.020 |
Why?
| Ploidies | 1 | 1992 | 17 | 0.020 |
Why?
| Serotonin | 1 | 1994 | 321 | 0.020 |
Why?
| Reference Values | 1 | 1994 | 791 | 0.020 |
Why?
| Ultraviolet Rays | 2 | 1985 | 386 | 0.020 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 2 | 1985 | 24 | 0.020 |
Why?
| Serine | 2 | 2003 | 133 | 0.020 |
Why?
| Clone Cells | 1 | 1992 | 258 | 0.020 |
Why?
| Cytokines | 1 | 1999 | 1997 | 0.020 |
Why?
| DNA Probes | 1 | 1990 | 61 | 0.020 |
Why?
| Cell Cycle Checkpoints | 1 | 2011 | 95 | 0.020 |
Why?
| Codon | 1 | 1990 | 88 | 0.020 |
Why?
| Peptide Chain Initiation, Translational | 1 | 1990 | 42 | 0.020 |
Why?
| Rabbits | 1 | 1991 | 757 | 0.020 |
Why?
| Neoplasms | 1 | 2004 | 2429 | 0.020 |
Why?
| Radioligand Assay | 1 | 1989 | 47 | 0.020 |
Why?
| Mitosis | 1 | 2011 | 177 | 0.020 |
Why?
| Acceleration | 1 | 1969 | 30 | 0.020 |
Why?
| Smad3 Protein | 1 | 2009 | 44 | 0.020 |
Why?
| Estrogen Receptor beta | 2 | 2000 | 34 | 0.020 |
Why?
| Cyanogen Bromide | 1 | 1989 | 1 | 0.020 |
Why?
| Formaldehyde | 1 | 1989 | 57 | 0.020 |
Why?
| Peptide Mapping | 1 | 1989 | 62 | 0.020 |
Why?
| Trypsin | 1 | 1989 | 73 | 0.020 |
Why?
| Antigen-Antibody Complex | 2 | 1987 | 84 | 0.020 |
Why?
| Mice, SCID | 1 | 2009 | 340 | 0.020 |
Why?
| Mesoderm | 1 | 2009 | 139 | 0.020 |
Why?
| Microtubules | 1 | 2011 | 252 | 0.020 |
Why?
| Endometrial Hyperplasia | 1 | 2008 | 11 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 1989 | 392 | 0.020 |
Why?
| Tissue Array Analysis | 1 | 2008 | 55 | 0.020 |
Why?
| Testosterone Congeners | 2 | 1979 | 8 | 0.020 |
Why?
| Perilipin-1 | 1 | 2008 | 16 | 0.020 |
Why?
| S100 Proteins | 1 | 2008 | 40 | 0.020 |
Why?
| Phosphorus Radioisotopes | 1 | 1987 | 30 | 0.020 |
Why?
| Mice, Inbred NOD | 1 | 2009 | 579 | 0.020 |
Why?
| Hysterectomy | 1 | 2008 | 118 | 0.020 |
Why?
| Gene Silencing | 1 | 2008 | 181 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1989 | 487 | 0.020 |
Why?
| DNA Primers | 2 | 1998 | 522 | 0.020 |
Why?
| 3-Hydroxysteroid Dehydrogenases | 1 | 1986 | 8 | 0.020 |
Why?
| Steroid Hydroxylases | 1 | 1986 | 21 | 0.020 |
Why?
| Protein C Inhibitor | 1 | 2006 | 1 | 0.020 |
Why?
| Chromatography, Thin Layer | 1 | 1986 | 23 | 0.020 |
Why?
| Chromatography, Gas | 1 | 1986 | 32 | 0.020 |
Why?
| Ligases | 1 | 2006 | 31 | 0.020 |
Why?
| Cadherins | 1 | 2008 | 186 | 0.020 |
Why?
| Insulin Receptor Substrate Proteins | 1 | 2006 | 59 | 0.020 |
Why?
| Half-Life | 1 | 1986 | 148 | 0.020 |
Why?
| RNA | 2 | 2005 | 877 | 0.020 |
Why?
| Stress, Physiological | 1 | 1969 | 413 | 0.020 |
Why?
| Heterotrimeric GTP-Binding Proteins | 1 | 2006 | 14 | 0.020 |
Why?
| Tacrolimus Binding Proteins | 1 | 2006 | 25 | 0.020 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2006 | 45 | 0.020 |
Why?
| Androstenes | 1 | 2005 | 17 | 0.020 |
Why?
| Levonorgestrel | 1 | 2005 | 34 | 0.020 |
Why?
| Polymerase Chain Reaction | 2 | 1998 | 1045 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 326 | 0.020 |
Why?
| Desogestrel | 1 | 2005 | 46 | 0.020 |
Why?
| Polymers | 1 | 1989 | 475 | 0.020 |
Why?
| 17-alpha-Hydroxyprogesterone | 1 | 1985 | 3 | 0.020 |
Why?
| Cell Fractionation | 2 | 1982 | 55 | 0.020 |
Why?
| Amino Acids | 1 | 1988 | 470 | 0.010 |
Why?
| Cricetinae | 2 | 1999 | 275 | 0.010 |
Why?
| Alkaline Phosphatase | 1 | 2005 | 148 | 0.010 |
Why?
| RNA Interference | 1 | 2006 | 448 | 0.010 |
Why?
| Molecular Chaperones | 1 | 2006 | 170 | 0.010 |
Why?
| Calcitriol | 1 | 1985 | 56 | 0.010 |
Why?
| Sucrose | 1 | 2004 | 93 | 0.010 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 1986 | 511 | 0.010 |
Why?
| Neoplasm Staging | 1 | 2008 | 1286 | 0.010 |
Why?
| Aged | 3 | 2012 | 22068 | 0.010 |
Why?
| Polyethylene Glycols | 1 | 1989 | 598 | 0.010 |
Why?
| Genes, Dominant | 1 | 2004 | 92 | 0.010 |
Why?
| Insulin-Like Growth Factor I | 1 | 2006 | 308 | 0.010 |
Why?
| Receptors, Adrenergic, beta | 1 | 1985 | 126 | 0.010 |
Why?
| Homeostasis | 1 | 1988 | 605 | 0.010 |
Why?
| NIH 3T3 Cells | 1 | 2004 | 142 | 0.010 |
Why?
| Carrier Proteins | 1 | 2008 | 731 | 0.010 |
Why?
| Chromatography, Gel | 1 | 1983 | 125 | 0.010 |
Why?
| Butadienes | 1 | 2003 | 35 | 0.010 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2003 | 50 | 0.010 |
Why?
| Lymphocytes | 1 | 1985 | 369 | 0.010 |
Why?
| Active Transport, Cell Nucleus | 1 | 2003 | 112 | 0.010 |
Why?
| Disease-Free Survival | 1 | 2004 | 657 | 0.010 |
Why?
| Fatty Acids, Unsaturated | 1 | 2003 | 93 | 0.010 |
Why?
| Nitriles | 1 | 2003 | 162 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 1982 | 77 | 0.010 |
Why?
| Hypophysectomy | 3 | 1977 | 15 | 0.010 |
Why?
| RNA, Small Interfering | 1 | 2004 | 577 | 0.010 |
Why?
| Lipid Metabolism | 1 | 1985 | 492 | 0.010 |
Why?
| Butyrates | 1 | 1982 | 53 | 0.010 |
Why?
| Cell Survival | 1 | 2004 | 1085 | 0.010 |
Why?
| Deoxyadenosines | 1 | 1980 | 9 | 0.010 |
Why?
| Dogs | 1 | 1982 | 372 | 0.010 |
Why?
| Proportional Hazards Models | 1 | 2004 | 1221 | 0.010 |
Why?
| Y-Box-Binding Protein 1 | 1 | 2000 | 5 | 0.010 |
Why?
| NFI Transcription Factors | 1 | 2000 | 8 | 0.010 |
Why?
| Diethylstilbestrol | 2 | 1979 | 9 | 0.010 |
Why?
| Clinical Trials as Topic | 1 | 1984 | 1005 | 0.010 |
Why?
| Culture Techniques | 1 | 1999 | 82 | 0.010 |
Why?
| Aorta | 1 | 1982 | 410 | 0.010 |
Why?
| Coumestrol | 1 | 1978 | 1 | 0.010 |
Why?
| Mycotoxins | 1 | 1978 | 3 | 0.010 |
Why?
| Coumarins | 1 | 1978 | 20 | 0.010 |
Why?
| Isoflavones | 1 | 1978 | 25 | 0.010 |
Why?
| Premenopause | 1 | 1999 | 126 | 0.010 |
Why?
| Flavonoids | 1 | 1978 | 79 | 0.010 |
Why?
| Subcellular Fractions | 1 | 1978 | 80 | 0.010 |
Why?
| Insulin | 1 | 1988 | 2313 | 0.010 |
Why?
| Gene Deletion | 1 | 1999 | 375 | 0.010 |
Why?
| Regression Analysis | 1 | 2000 | 987 | 0.010 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 1998 | 321 | 0.010 |
Why?
| Remission, Spontaneous | 1 | 1977 | 38 | 0.010 |
Why?
| Recurrence | 2 | 1978 | 1013 | 0.010 |
Why?
| Adrenal Glands | 1 | 1977 | 73 | 0.010 |
Why?
| Postmenopause | 1 | 1999 | 366 | 0.010 |
Why?
| Hypersensitivity | 1 | 2000 | 277 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2008 | 7063 | 0.010 |
Why?
| Sex Factors | 1 | 1982 | 1950 | 0.010 |
Why?
| Fluoxymesterone | 1 | 1975 | 2 | 0.010 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1984 | 1572 | 0.010 |
Why?
| Mice, Inbred C57BL | 1 | 2006 | 5282 | 0.010 |
Why?
| Ovary | 1 | 1977 | 212 | 0.010 |
Why?
| Nucleic Acid Conformation | 1 | 1997 | 705 | 0.010 |
Why?
| Cattle | 1 | 1994 | 973 | 0.010 |
Why?
| Clostridium tetani | 1 | 1969 | 1 | 0.010 |
Why?
| Nystagmus, Pathologic | 1 | 1969 | 10 | 0.010 |
Why?
| Treatment Outcome | 1 | 2004 | 10256 | 0.010 |
Why?
| Peptides | 1 | 1994 | 904 | 0.000 |
Why?
| Genetic Vectors | 1 | 1990 | 312 | 0.000 |
Why?
| Corticosterone | 1 | 1969 | 214 | 0.000 |
Why?
| Salmonella typhimurium | 1 | 1969 | 174 | 0.000 |
Why?
| Hybridomas | 1 | 1987 | 234 | 0.000 |
Why?
| Male | 3 | 1999 | 63248 | 0.000 |
Why?
| Adrenalectomy | 2 | 1977 | 67 | 0.000 |
Why?
| Pindolol | 1 | 1985 | 15 | 0.000 |
Why?
| Mice, Inbred BALB C | 1 | 1987 | 1230 | 0.000 |
Why?
| Blood Proteins | 1 | 1985 | 233 | 0.000 |
Why?
| Solubility | 1 | 1980 | 233 | 0.000 |
Why?
| Zeranol | 1 | 1978 | 1 | 0.000 |
Why?
| Zearalenone | 1 | 1978 | 2 | 0.000 |
Why?
| Sex Hormone-Binding Globulin | 1 | 1978 | 53 | 0.000 |
Why?
| Aminoglutethimide | 1 | 1977 | 5 | 0.000 |
Why?
| Species Specificity | 1 | 1976 | 568 | 0.000 |
Why?
|
|
Horwitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|